Brief: PCI Biotech Says Expansion Of Preclinical Research Collaboration Agreement With Astrazeneca
26/11/2019 17:11
Nov 26 (Reuters) - PCI Biotech Holding ASA PCIB.OL :
* REG-PCI BIOTECH: EXPANSION OF PRECLINICAL RESEARCH
COLLABORATION
AGREEMENT WITH ASTRAZENECA
* PCI BIOTECH HOLDING -COLLABORATION RUNS TO END OF 2019 AND
CO'S
HAVE AGREED TO USE FOLLOWING 6 MONTHS TO EVALUATE POTENTIAL FOR
FURTHER COLLABORATION.
Source text for Eikon: ID:nGNE7Rjng3
Further company coverage: PCIB.OL
((Reuters.Briefs@thomsonreuters.com;))
Recent news on PCI Biotech Holding ASA
See all newsBrief: Euronext Oslo Børs To Delist PCI Biotech Holding Shares
Brief: Euronext Oslo Børs Gets Application From PCI Biotech Holding For Delisting
Brief: PCI Biotech Holding Board Proposes Dissolution, Delisting
Brief: Oslo Bors: PCI Biotech Holding Is Placed In Recovery Box
Brief: PCI Biotech Says Co Initiates Process To Evaluate Opportunity For Structured Wind-Up Process